Skip to search formSkip to main contentSkip to account menu

AD 1590

Known as: AD-1590 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

bermoprofen

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
[Inhibitory effect of AD-1590, a non-steroidal anti-inflammatory drug, on allergic inflammation in mice and rats].
Effect of AD-1590 on allergic inflammations was investigated. AD-1590 and indomethacin at an oral dosage as high as 32 mg/kg did… 
1988
1988
Clinical study of the antipyretic analgesic AD-1590 in pain after difficult tooth extraction
A double-blind study of the antipyretic analgesic AD-1590 20 mg (Group A) was conducted to evaluate its utility in pain after… 
1988
1988
[A correlation between the species differences in anti-inflammatory activity of AD-1590, a non-steroidal anti-inflammatory drug, and its plasma level].
Authors have reported that the oral potency ratio of AD-1590 to indomethacin varies with the animal models employed; the ratio is… 
1988
1988
[Mode of anti-inflammatory action of a non-steroidal anti-inflammatory drug, AD-1590].
1986
1986
Influence of pharmaceutical properties on gastric lesions induced in rats by AD-1590, a non-steroidal anti-inflammatory drug.
The influence of pharmaceutical properties on the gastric lesions induced by AD-1590 (AD), a non-steroidal anti-inflammatory drug… 
1986
1986
Effect of AD-1590, a non-steroidal anti-inflammatory agent with a potent antipyretic activity, on in vitro prostaglandin generation in rabbit brain.
The inhibitory activity of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl) propionic acid (AD-1590) against prostaglandin… 
1985
1985
Inhibition of prostaglandin generation in the rabbit brain in‐vivo by AD‐1590, a non‐steroidal antiinflammatory agent with potent antipyretic activity
The inhibition of prostaglandin generation by AD‐1590 was investigated in the rabbit brain in‐vivo. AD‐1590 (0ṁ4 mg kg−1 i.v… 
1984
1984
AD‐1590, a potent antagonist of lipopolysaccharide‐induced fever in rabbits
The antipyretic activity of AD‐1590 (2‐[8‐methyl‐10,11‐oxodibenz[b,f]oxepin‐2‐yl]propionic acid), a non‐steroidal anti… 
1984
1984
Central versus peripheral sites of antipyretic action of a non-steroidal anti-inflammatory agent, AD-1590, in rabbits
AbstractsThe site of antipyretic action of AD-1590 in the sequential process involved in the development of fever caused by… 
1983
1983
The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.
Anti-inflammatory, analgesic, antipyretic and gastrointestinal ulcerogenic activities of 2-(8-methyl-10,11-dihydro-11-oxodibenz(b… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)